Stenocare AS (OCSE:STENO) Days Sales Outstanding : 84.87 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS Days Sales Outstanding?

Stenocare AS's average Accounts Receivable for the three months ended in Dec. 2024 was kr1.17 Mil. Stenocare AS's Revenue for the three months ended in Dec. 2024 was kr1.26 Mil. Hence, Stenocare AS's Days Sales Outstanding for the three months ended in Dec. 2024 was 84.87.

The historical rank and industry rank for Stenocare AS's Days Sales Outstanding or its related term are showing as below:

OCSE:STENO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.33 Med: 279.91 Max: 299.67
Current: 250.66

During the past 7 years, Stenocare AS's highest Days Sales Outstanding was 299.67. The lowest was 24.33. And the median was 279.91.

OCSE:STENO's Days Sales Outstanding is ranked worse than
95.52% of 959 companies
in the Drug Manufacturers industry
Industry Median: 72.47 vs OCSE:STENO: 250.66

Stenocare AS's Days Sales Outstanding declined from Dec. 2023 (128.07) to Dec. 2024 (84.87).

Stenocare AS Days Sales Outstanding Historical Data

The historical data trend for Stenocare AS's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS Days Sales Outstanding Chart

Stenocare AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

24.33

294.68

291.23

299.67

Stenocare AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															128.07	175.70	180.79	-	84.87

Competitive Comparison of Stenocare AS's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stenocare AS's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Stenocare AS's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Stenocare AS Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Stenocare AS's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (2.372	+	1.293)	/	2 )	/	2.232	*	365
=	1.8325					/	2.232	*	365
=	299.67

Stenocare AS's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (1.047	+	1.293)	/	2 )	/	1.258	*	365 / 4
=	1.17					/	1.258	*	365 / 4
=	84.87

Stenocare AS (OCSE:STENO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Stenocare AS Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Stenocare AS's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Stenocare AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nyholmsvej 4, Randers NØ, DNK, 8930

Website

https://www.stenocare.com

Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines